Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Alcon (ALC) Receives a Buy from RBC Capital

Tipranks - Tipranks - Thu Feb 19, 5:40AM CST

In a report released yesterday, Jack Reynolds-Clark from RBC Capital reiterated a Buy rating on Alcon, with a price target of CHF80.00.

President's Day Sale - 70% Off

Reynolds-Clark covers the Healthcare sector, focusing on stocks such as Alcon, Smith & Nephew, and ConvaTec. According to TipRanks, Reynolds-Clark has an average return of 2.6% and a 45.10% success rate on recommended stocks.

Currently, the analyst consensus on Alcon is a Moderate Buy with an average price target of CHF73.90.

See the top stocks recommended by analysts >>

Based on Alcon’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of CHF2.61 billion and a net profit of CHF237 million. In comparison, last year the company earned a revenue of CHF2.45 billion and had a net profit of CHF263 million

Read More on ALC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).